Targeted therapy and hematopoietic stem cell transplantation have revolutionized blood cancer treatment by focusing on precision and regeneration. These methods minimize systemic toxicity and optimize patient outcomes, signaling a paradigm shift in oncological care rooted in molecular biology and immunoengineering.